Apellis Pharmaceuticals Inc (APLS) Ownership

41.05 ↑1.76 (4.48%)
As of August 30, 2024, 4:00pm EST.

Institutional Ownership

Wellington Management Company LLP is the biggest individual institutional holder of Apellis Pharmaceuticals Inc (APLS), owning a total of 15.1 million shares. Combined, the top 35 institutional holders of APLS own 85.99% of the company with a total of 104.1 million shares.

In the latest ownership report on March 31st 2024, the top 35 institutional holders decreased their combined ownership of APLS by 4.2 million shares. 8 institutions bought 1,603,942 total additional shares and increased their ownership by an average of 17.95%. However 12 institutions sold 5,818,440 total shares and decreased their ownership by an average of 11.83%.

Overall this is a negative sign as the number of shares owned by the top 20 institutional holders of Apellis Pharmaceuticals decreased by a net total of -4,214,498 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Wellington Management Company LLP12.366%-8.435%15,058,071-1,387,2192024-03-31
EcoR1 Capital, LLC9.327%1.650%11,357,425184,3572024-03-31
venBio Select Advisor LLC9.125%0.000%11,111,11102024-03-31
Vanguard Group Inc7.807%-0.521%9,505,866-49,8122024-03-31
BlackRock Inc4.512%2.106%5,494,591113,3382024-03-31
T. Rowe Price Investment Management,Inc.3.782%-26.935%4,605,721-1,697,8632024-03-31
Jennison Associates LLC2.661%-1.081%3,240,513-35,4092024-03-31
State Street Corporation2.389%-0.202%2,909,528-5,8942024-03-31
Octagon Capital Advisors LP2.305%-10.320%2,806,980-323,0202024-03-31
T. Rowe Price Associates, Inc.2.020%-0.044%2,459,246-1,0932024-03-31
JPMorgan Chase & Co1.819%-13.979%2,214,309-359,8242024-03-31
FMR Inc1.789%4.123%2,178,74286,2782024-03-31
Assenagon Asset Management SA1.667%-5.659%2,023,614-121,3902024-03-31
Boxer Capital LLC1.418%0.000%1,726,00002024-03-31
Geode Capital Management, LLC1.388%3.633%1,689,89059,2482024-03-31
Morgan Stanley - Brokerage Accounts1.345%-47.125%1,637,618-1,459,5232024-03-31
Deutsche Bank AG1.324%88.072%1,611,773754,7742024-03-31
Artal Group S A1.080%-7.462%1,315,282-106,0642024-03-31
Orbimed Advisors, LLC1.066%40.729%1,297,800375,6002024-03-31
Pictet Asset Manangement SA0.881%-20.180%1,073,234-271,3292024-03-31
Polar Capital Holdings PLC0.866%0.095%1,054,4401,0002024-03-31
Fiera Capital Corporation0.782%3.193%948,43729,3472024-03-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Wellington Management Company LLP12.366%-8.435%15,058,071-1,387,2192024-03-31
EcoR1 Capital, LLC9.327%1.650%11,357,425184,3572024-03-31
venBio Select Advisor LLC9.125%0.000%11,111,11102024-03-31
Vanguard Group Inc7.807%-0.521%9,505,866-49,8122024-03-31
BlackRock Inc4.512%2.106%5,494,591113,3382024-03-31
T. Rowe Price Investment Management,Inc.3.782%-26.935%4,605,721-1,697,8632024-03-31
Jennison Associates LLC2.661%-1.081%3,240,513-35,4092024-03-31
State Street Corporation2.389%-0.202%2,909,528-5,8942024-03-31
Octagon Capital Advisors LP2.305%-10.320%2,806,980-323,0202024-03-31
T. Rowe Price Associates, Inc.2.020%-0.044%2,459,246-1,0932024-03-31
JPMorgan Chase & Co1.819%-13.979%2,214,309-359,8242024-03-31
FMR Inc1.789%4.123%2,178,74286,2782024-03-31
Slate Path Capital LP1.745%0.000%2,068,0002,068,0002023-09-30
Assenagon Asset Management SA1.667%-5.659%2,023,614-121,3902024-03-31
Cormorant Asset Management, LLC1.688%52.672%2,000,000690,0002023-09-30
HHG PLC1.500%-62.044%1,776,905-2,904,5772023-06-30
Boxer Capital LLC1.418%0.000%1,726,00002024-03-31
Geode Capital Management, LLC1.388%3.633%1,689,89059,2482024-03-31
Morgan Stanley - Brokerage Accounts1.345%-47.125%1,637,618-1,459,5232024-03-31
Deutsche Bank AG1.324%88.072%1,611,773754,7742024-03-31
Marshall Wace Asset Management Ltd1.238%49.526%1,368,407453,2442022-06-30
Artal Group S A1.080%-7.462%1,315,282-106,0642024-03-31
Orbimed Advisors, LLC1.066%40.729%1,297,800375,6002024-03-31
Point72 Asset Management, L.P.1.046%-34.067%1,239,361-640,3632023-06-30
Amvescap Plc.0.973%10.703%1,152,396111,4152023-06-30
Bellevue Group AG0.942%0.468%1,109,3825,1652023-03-31
Macquarie Group Ltd0.893%38.823%1,076,548301,0682023-09-30
Pictet Asset Manangement SA0.881%-20.180%1,073,234-271,3292024-03-31
Lord, Abbett & Co LLC0.901%18.128%1,068,143163,9152023-06-30
Goldman Sachs Group Inc0.914%10.862%1,061,703104,0252022-12-31
Polar Capital Holdings PLC0.866%0.095%1,054,4401,0002024-03-31
Logos Global Management LP0.783%26.667%950,000200,0002023-12-31
Charles Schwab Investment Management Inc0.858%39.852%948,759270,3582022-09-30
Fiera Capital Corporation0.782%3.193%948,43729,3472024-03-31
NORGES BANK0.791%-9.665%946,213-101,2412023-12-31

Mutual Fund Ownership

Vanguard Health Care Inv is the biggest individual fund holder of Apellis Pharmaceuticals Inc (APLS), owning a total of 9.5 million shares. Combined, the top 42 mutual fund holders of APLS own 51.55% of the company with a total of 62 million shares.

In the latest ownership report on July 31st 2024, the top 42 fund holders increased their combined ownership of APLS by 101 thousand shares. 4 funds bought 120,162 total additional shares and increased their ownership by an average of 2.04%. However 3 funds sold 19,631 total shares and decreased their ownership by an average of 0.49%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Apellis Pharmaceuticals increased by a net total of 100,531 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Total Stock Mkt Idx Inv2.702%-0.238%3,289,887-7,8532024-07-31
Vanguard Small Cap Index2.139%0.424%2,604,33211,0072024-07-31
SPDR® S&P Biotech ETF2.117%0.445%2,578,29511,4242024-07-31
Vanguard Institutional Extnd Mkt Idx Tr1.306%0.661%1,590,67710,4502024-07-31
Vanguard Small Cap Growth Index Inv1.192%-0.384%1,450,978-5,5862024-07-31
PGIM Jennison Health Sciences Z1.155%6.620%1,405,78487,2812024-07-31
iShares Biotechnology ETF0.604%-0.835%735,842-6,1922024-07-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Health Care Inv7.805%0.000%9,503,37502024-06-30
Vanguard Total Stock Mkt Idx Inv2.702%-0.238%3,289,887-7,8532024-07-31
Vanguard Instl Ttl Stck Mkt Idx Tr2.548%5.841%3,019,782166,6522023-03-31
Vanguard Small Cap Index2.139%0.424%2,604,33211,0072024-07-31
SPDR® S&P Biotech ETF2.117%0.445%2,578,29511,4242024-07-31
iShares Russell 2000 ETF1.829%0.292%2,130,0556,1912023-06-21
US Small-Cap Growth II Equity Comp1.508%0.000%1,787,1001,787,1002023-06-30
T. Rowe Price New Horizons1.518%26.430%1,787,100373,5952023-06-30
Hartford MidCap Y1.462%-1.839%1,780,645-33,3632024-06-30
Vanguard Institutional Extnd Mkt Idx Tr1.306%0.661%1,590,67710,4502024-07-31
Vanguard Small Cap Growth Index Inv1.192%-0.384%1,450,978-5,5862024-07-31
PGIM Jennison Health Sciences Z1.155%6.620%1,405,78487,2812024-07-31
Vanguard Extended Market Index Investor1.175%0.507%1,383,2026,9732023-08-31
T. Rowe Price US Mid-Cap Growth Equity1.102%-0.208%1,341,400-2,8002024-06-30
T. Rowe Price Mid-Cap Growth1.102%-0.208%1,341,400-2,8002024-06-30
Jennison Health Sciences Equity1.083%14.247%1,318,503164,4242024-06-30
T. Rowe Price Health Sciences1.064%-2.233%1,291,193-29,4942024-03-31
Fidelity® Select Biotechnology1.080%4.611%1,279,47956,4002023-11-30
Fidelity Select Biotechnology0.971%-7.839%1,182,779-100,6002024-06-30
T. Rowe Price Small-Cap Stock0.908%-0.147%1,086,076-1,6002023-12-31
T. Rowe Price US Small-Cap Core Equity0.908%-0.147%1,086,076-1,6002023-12-31
DWS Vermögensbildungsfonds I LD0.871%0.000%1,060,031-22024-06-30
JPM US Mid Cap Growth-Composite0.828%45.408%1,007,950314,7612024-06-30
JPMorgan Mid Cap Growth I0.828%0.000%1,007,95002024-06-30
Polar Capital Biotech S Inc0.821%0.000%1,000,00002024-06-30
Janus Henderson US Opportunistic Alpha0.831%20.549%968,013165,0102023-03-31
Janus Henderson Contrarian D0.831%20.549%968,013165,0102023-03-31
Vanguard Explorer Inv0.788%43.548%959,621291,1182024-06-30
Janus Henderson Global Life Sciences D0.759%6.432%883,42953,3842023-03-31
Janus Henderson Global Life Sciences0.759%6.432%883,42953,3842023-03-31
T. Rowe Price Small-Cap Value0.759%-0.177%844,169-1,5002022-12-31
Fidelity® Small Cap Index0.698%1.669%821,43913,4882023-05-31
Worldwide Healthcare Ord0.657%0.000%800,00002024-04-30
Bellevue Healthcare Ord0.643%36.304%782,306208,3622023-11-30
Eagle Mid-Cap Growth - Institutional0.625%-4.629%761,386-36,9572024-06-30
Macquarie US Small Cap Core Equity0.636%21.308%753,839132,4152023-09-30
Delaware Small Cap Core I0.636%0.000%753,83902023-11-30
Lord Abbett Developing Growth A0.637%1.432%749,79510,5862023-06-30
iShares Biotechnology ETF0.604%-0.835%735,842-6,1922024-07-31
JPM US Mid Cap Growth-MA0.591%268.730%695,794507,0942023-09-30
PGIM Jennison Small Company A0.561%0.000%660,48402023-08-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.520%0.323%621,2462,0002024-03-31

Discussions

Please log in or register to share your thoughts.